These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 28797748)

  • 1. Renal trials in diabetes need a platform: time for a global approach?
    de Zeeuw D; Heerspink HJL; Jardine M; Perkovic V
    Lancet Diabetes Endocrinol; 2018 May; 6(5):356-358. PubMed ID: 28797748
    [No Abstract]   [Full Text] [Related]  

  • 2. Increased prevalence of renal biopsy findings other than diabetic glomerulopathy in type II diabetes mellitus.
    Richards NT; Greaves I; Lee SJ; Howie AJ; Adu D; Michael J
    Nephrol Dial Transplant; 1992; 7(5):397-9. PubMed ID: 1321374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative incidence of ESRD versus cardiovascular mortality in proteinuric type 2 diabetes and nephropathy: results from the DIAMETRIC (Diabetes Mellitus Treatment for Renal Insufficiency Consortium) database.
    Packham DK; Alves TP; Dwyer JP; Atkins R; de Zeeuw D; Cooper M; Shahinfar S; Lewis JB; Lambers Heerspink HJ
    Am J Kidney Dis; 2012 Jan; 59(1):75-83. PubMed ID: 22051245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diabetes mellitus, hypertension and kidney].
    Monhart V
    Vnitr Lek; 2008 May; 54(5):499-504, 507. PubMed ID: 18630636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The diabetic patient with renal insufficiency.
    Vanhille P
    Diabetes Metab; 2000 Jul; 26 Suppl 4():67-72. PubMed ID: 10922976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical identification of nondiabetic renal disease in diabetic patients with type I and type II disease presenting with renal dysfunction.
    Amoah E; Glickman JL; Malchoff CD; Sturgill BC; Kaiser DL; Bolton WK
    Am J Nephrol; 1988; 8(3):204-11. PubMed ID: 3239594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Causes of renal failure in patients with type 2 diabetes mellitus.
    Kida Y
    JAMA; 2003 Oct; 290(14):1855; author reply 1855-6. PubMed ID: 14532311
    [No Abstract]   [Full Text] [Related]  

  • 8. Renal segmental hypoplasia, Ask-Upmark kidney, in a patient with microalbuminuric hypertensive type 2 diabetes mellitus.
    Fuke T; Sugimoto T; Ugi S; Omura Y; Nishio Y; Maegawa H; Kashiwagi A
    Diabetes Res Clin Pract; 2008 Apr; 80(1):e22-4. PubMed ID: 18178284
    [No Abstract]   [Full Text] [Related]  

  • 9. Association between plasma triglycerides and high-density lipoprotein cholesterol and microvascular kidney disease and retinopathy in type 2 diabetes mellitus: a global case-control study in 13 countries.
    Sacks FM; Hermans MP; Fioretto P; Valensi P; Davis T; Horton E; Wanner C; Al-Rubeaan K; Aronson R; Barzon I; Bishop L; Bonora E; Bunnag P; Chuang LM; Deerochanawong C; Goldenberg R; Harshfield B; Hernández C; Herzlinger-Botein S; Itoh H; Jia W; Jiang YD; Kadowaki T; Laranjo N; Leiter L; Miwa T; Odawara M; Ohashi K; Ohno A; Pan C; Pan J; Pedro-Botet J; Reiner Z; Rotella CM; Simo R; Tanaka M; Tedeschi-Reiner E; Twum-Barima D; Zoppini G; Carey VJ
    Circulation; 2014 Mar; 129(9):999-1008. PubMed ID: 24352521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The kidney in type 2 diabetes: focus on renal structure.
    Dalla Vestra M; Arboit M; Bruseghin M; Fioretto P
    Endocrinol Nutr; 2009 Dec; 56 Suppl 4():18-20. PubMed ID: 20629225
    [No Abstract]   [Full Text] [Related]  

  • 11. Renal redox stress and remodeling in metabolic syndrome, type 2 diabetes mellitus, and diabetic nephropathy: paying homage to the podocyte.
    Hayden MR; Whaley-Connell A; Sowers JR
    Am J Nephrol; 2005; 25(6):553-69. PubMed ID: 16210838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural Predictors of Loss of Renal Function in American Indians with Type 2 Diabetes.
    Fufaa GD; Weil EJ; Lemley KV; Knowler WC; Brosius FC; Yee B; Mauer M; Nelson RG
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):254-61. PubMed ID: 26792530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Hyperfiltering Kidney in Diabetes.
    Trevisan R; Dodesini AR
    Nephron; 2017; 136(4):277-280. PubMed ID: 27978521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Magistral and intrarenal blood flow in type 2 diabetes mellitus patients with kidney lesions].
    Georgian Med News; 2014 Sep; (234):56-60. PubMed ID: 25341239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antihypertensive treatment in type II diabetes and diabetic nephropathy].
    Chantrel F; Bouiller M; Kolb I; Hannedouche T
    Nephrologie; 2000; 21(2):47-55. PubMed ID: 10798204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The kidney in diabetes].
    Favre H
    Rev Med Suisse Romande; 1995 Sep; 115(9):717-20. PubMed ID: 7481360
    [No Abstract]   [Full Text] [Related]  

  • 17. Non-diabetic renal disease with or without diabetic nephropathy in type 2 diabetes: clinical predictors and outcome.
    Soleymanian T; Hamid G; Arefi M; Najafi I; Ganji MR; Amini M; Hakemi M; Tehrani MR; Larijani B
    Ren Fail; 2015 May; 37(4):572-5. PubMed ID: 25682971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening tests for renal impairment in patients with type 2 diabetes: the what, when, and how.
    Palmer BF
    Postgrad Med; 2011 Jan; 123(1):7-14. PubMed ID: 21293079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal structure and function in type 2 diabetic patients with or without diabetic nephropathy.
    Christensen PK
    Dan Med Bull; 2004 Feb; 51(1):82-103. PubMed ID: 16009073
    [No Abstract]   [Full Text] [Related]  

  • 20. Is Chronic Dialysis the Right Hard Renal End Point To Evaluate Renoprotective Drug Effects?
    Weldegiorgis M; de Zeeuw D; Dwyer JP; Mol P; Heerspink HJL
    Clin J Am Soc Nephrol; 2017 Oct; 12(10):1595-1600. PubMed ID: 28923834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.